Share Facebook Twitter LinkedIn Pinterest Email First National GAAP EPS of -$0.14, revenue of $13.88M
Roche lung cancer drug extends survival by nearly six months in late-stage trial (RHHBY:OTCMKTS)October 25, 2026
